aspirin has been researched along with caffeic acid in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 11 (55.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carbonneau, MA; Cartron, E; Descomps, B; Fouret, G; Léger, CL | 1 |
| Bohlin, L; Huss, U; Perera, P; Ringbom, T; Vasänge, M | 1 |
| Chen, QH; Knaus, EE; Rao, PN | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Abdellatif, KR; Chowdhury, MA; Das, D; Dong, Y; Knaus, EE; Suresh, MR | 1 |
| Abdellatif, KR; Chowdhury, MA; Das, D; Dong, Y; Knaus, EE; Rahman, M; Suresh, MR | 1 |
| Antonini, G; Cechinel Filho, V; de Campos Buzzi, F; Fracasso, M; Franzoi, CL; Niero, R; Yunes, RA | 1 |
| Coy, ED; Cuca, LE; Sefkow, M | 1 |
| Abdellatif, KR; Chowdhury, MA; Das, D; Dong, Y; Knaus, EE; Suresh, MR; Velázquez, CA; Yu, G | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Miyazawa, M; Takahashi, T | 1 |
| Chang, WC; Huang, JD; Lin, MT; Ning, CC | 1 |
| Bond, JA; Calder, PC; Newsholme, EA | 1 |
| Ali, S; Molinari, LM; Wells, PG; Wong, ST; Zubovits, JT | 1 |
| Estacion, M; Mordan, LJ; Wang, Z | 1 |
| Hammerschmidt, S; Wahn, H | 1 |
| Bienkiewicz, B; Jedrzejczak-Czechowicz, M; Kowalski, ML; Lewandowska-Polak, A | 1 |
| Chen, X; Gong, P; Hao, H; Li, F; Shi, H; Sun, S; Tang, Z; Wang, G | 1 |
| Antonov, VG; Butov, SN; Krutetskaia, NI; Krutetskaia, ZI; Kurilova, LS; Naumova, AA | 1 |
| Dash, S; Kar, D; Ray, M; Sahrawat, TR; Shahbazi, S; Singh, S | 1 |
20 other study(ies) available for aspirin and caffeic acid
| Article | Year |
|---|---|
Specific antioxidant activity of caffeoyl derivatives and other natural phenolic compounds: LDL protection against oxidation and decrease in the proinflammatory lysophosphatidylcholine production.
Topics: Antioxidants; Caffeic Acids; Humans; Inflammation Mediators; Lipoproteins, LDL; Lysophosphatidylcholines; Oxidation-Reduction; Phenols | 2001 |
Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.
Topics: Acrolein; Alkaloids; Animals; Anthraquinones; Aspirin; Biological Assay; Catalysis; Cinnamomum zeylanicum; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Eugenol; Flavonoids; Indomethacin; Inhibitory Concentration 50; Isoenzymes; Kinetics; Lactones; Models, Molecular; Nitrobenzenes; Oleanolic Acid; Plants, Medicinal; Prostaglandin-Endoperoxide Synthases; Pyrogallol; Steroids; Sulfonamides; Sulfones; Syzygium; Terpenes; Triterpenes; Ursolic Acid | 2002 |
Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Topics: Administration, Oral; Alkynes; Analgesics; Animals; Arachidonate 15-Lipoxygenase; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Edema; Lipoxygenase Inhibitors; Mice; Models, Molecular; Pain Measurement; Rats; Structure-Activity Relationship | 2006 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caffeic Acids; Celecoxib; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Design; Edema; Foot; Lipoxygenase Inhibitors; Molecular Structure; Pyrazoles; Pyridones; Rats; Structure-Activity Relationship; Sulfonamides | 2008 |
Synthesis of 1-(methanesulfonyl- and aminosulfonylphenyl)acetylenes that possess a 2-(N-difluoromethyl-1,2-dihydropyridin-2-one) pharmacophore: evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
Topics: Acetylene; Alkynes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Drug Design; Ibuprofen; Inflammation; Inhibitory Concentration 50; Isoenzymes; Lipoxygenase Inhibitors; Models, Chemical; Pyridones; Rats | 2009 |
Antinociceptive properties of caffeic acid derivatives in mice.
Topics: Analgesics; Animals; Caffeic Acids; Mice; Molecular Structure; Pain; Structure-Activity Relationship | 2009 |
COX, LOX and platelet aggregation inhibitory properties of Lauraceae neolignans.
Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Lauraceae; Lipoxygenase Inhibitors; Platelet Aggregation Inhibitors; Rabbits | 2009 |
Synthesis and biological evaluation of salicylic acid and N-acetyl-2-carboxybenzenesulfonamide regioisomers possessing a N-difluoromethyl-1,2-dihydropyrid-2-one pharmacophore: dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory ac
Topics: Aspirin; Cyclooxygenase 2 Inhibitors; Humans; Isomerism; Lipoxygenase Inhibitors; Pyridones; Salicylates; Sulfonamides | 2009 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
N-Caffeoyl serotonin as selective COX-2 inhibitor.
Topics: Anti-Inflammatory Agents; Aspirin; Biological Assay; Caffeic Acids; Catechols; Cinnamates; Coumaric Acids; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Humans; Serotonin | 2012 |
Epidermal growth factor enhances a microsomal 12-lipoxygenase activity in A431 cells.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Animals; Arachidonate 12-Lipoxygenase; Arachidonic Acid; Aspirin; Caffeic Acids; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Cycloheximide; Epidermal Growth Factor; Humans; Hydroxyeicosatetraenoic Acids; Indomethacin; Lipoxygenase Inhibitors; Masoprocol; Mice; Microsomes; NADP; Stereoisomerism; Substrate Specificity; Tumor Cells, Cultured | 1992 |
Effect of inhibitors of eicosanoid synthesis upon lymphocyte proliferation.
Topics: Animals; Aspirin; Caffeic Acids; Cells, Cultured; DNA Replication; Eicosanoids; Indomethacin; Lymph Nodes; Lymphocyte Activation; Male; Masoprocol; Quinacrine; Rats; T-Lymphocytes; Thymidine | 1991 |
Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Biotransformation; Caffeic Acids; Cinnamates; Cyclic N-Oxides; Cytochrome P-450 Enzyme System; Embryo, Mammalian; Female; Fetal Resorption; Free Radicals; Mice; Nitrogen Oxides; Phenytoin; Pregnancy; Prostaglandin-Endoperoxide Synthases | 1989 |
Ca2+ influx via T-type channels modulates PDGF-induced replication of mouse fibroblasts.
Topics: Animals; Aspirin; Caffeic Acids; Calcium; Calcium Channels; Cell Division; Cell Line; Evoked Potentials; Fibroblasts; Indomethacin; Kinetics; Masoprocol; Membrane Potentials; Mice; Mice, Inbred C3H; Platelet-Derived Growth Factor; S Phase; Time Factors | 1993 |
Influence of cyclooxygenase and lipoxygenase inhibitors on oxidative stress-induced lung injury.
Topics: Animals; Antioxidants; Aspirin; Caffeic Acids; Capillary Permeability; Cyclooxygenase Inhibitors; Hypochlorous Acid; Lipoxygenase Inhibitors; Lung; Oxidative Stress; Pulmonary Wedge Pressure; Rabbits | 2001 |
Involvement of 15-lipoxygenase and prostaglandin EP receptors in aspirin-triggered 15-hydroxyeicosatetraenoic acid generation in aspirin-sensitive asthmatics.
Topics: Adolescent; Adult; Aged; Arachidonate 15-Lipoxygenase; Aspirin; Asthma; Caffeic Acids; Dinoprostone; Drug Hypersensitivity; Female; Humans; Hydroxyeicosatetraenoic Acids; Leukocytes; Lipoxygenase Inhibitors; Male; Middle Aged; Misoprostol; Receptors, Prostaglandin E | 2008 |
Protocatechualdehyde synergizes with aspirin at the platelet cyclooxygenase-1 level.
Topics: Animals; Anticoagulants; Antioxidants; Arachidonic Acid; Aspirin; Benzaldehydes; Blood Platelets; Caffeic Acids; Catechols; Cyclooxygenase 1; Drug Synergism; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Binding; Rabbits | 2011 |
[The effect of cyclooxygenase and lipoxygenase inhibitors on Ca(2+)-responses induced by glutoxim and molixan in macrophages].
Topics: Animals; Arachidonic Acid; Aspirin; Caffeic Acids; Calcium; Calcium Signaling; Cyclooxygenase Inhibitors; Flavanones; Hematinics; Indomethacin; Lipoxygenase Inhibitors; Macrophages, Peritoneal; Masoprocol; Oligopeptides; Primary Cell Culture; Rats; Rats, Wistar | 2014 |
Drug Targets for Cardiovascular-Safe Anti-Inflammatory: In Silico Rational Drug Studies.
Topics: Anti-Inflammatory Agents; Aspirin; Binding Sites; Caffeic Acids; Celecoxib; Coumaric Acids; Cyclooxygenase 1; Cyclooxygenase 2; ERG1 Potassium Channel; Eugenol; Heart; Humans; Inflammation; Integrin alpha2; Protein Structure, Tertiary; Tirofiban; Tyrosine | 2016 |